Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 5.34 -0.14 (2.55%)
Previous Close $5.48    52 Week High
Open $5.40    52 Week Low
Day High $5.49    P/E N/A 
Day Low $5.29    EPS
Volume 1,810,761       

(NASDAQ: TSHA) Delayed: 5.34 -0.14 (2.55%)
Previous Close $5.48    52 Week High
Open $5.40    52 Week Low
Day High $5.49    P/E N/A 
Day Low $5.29    EPS
Volume 1,810,761